IL154685A0 - 2-,3-,4-, or 5-substituted-n1-(benzensulfonyl) indoles and their use in therapy - Google Patents
2-,3-,4-, or 5-substituted-n1-(benzensulfonyl) indoles and their use in therapyInfo
- Publication number
- IL154685A0 IL154685A0 IL15468501A IL15468501A IL154685A0 IL 154685 A0 IL154685 A0 IL 154685A0 IL 15468501 A IL15468501 A IL 15468501A IL 15468501 A IL15468501 A IL 15468501A IL 154685 A0 IL154685 A0 IL 154685A0
- Authority
- IL
- Israel
- Prior art keywords
- benzensulfonyl
- indoles
- therapy
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0003810A SE0003810D0 (sv) | 2000-10-20 | 2000-10-20 | Novel compounds their use and preparations |
| US24311500P | 2000-10-25 | 2000-10-25 | |
| PCT/SE2001/002319 WO2002032863A1 (en) | 2000-10-20 | 2001-10-19 | 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL154685A0 true IL154685A0 (en) | 2003-09-17 |
Family
ID=26655269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15468501A IL154685A0 (en) | 2000-10-20 | 2001-10-19 | 2-,3-,4-, or 5-substituted-n1-(benzensulfonyl) indoles and their use in therapy |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7087750B2 (xx) |
| EP (1) | EP1326830A1 (xx) |
| KR (1) | KR100823908B1 (xx) |
| AU (2) | AU9619301A (xx) |
| BR (1) | BR0114552A (xx) |
| CA (1) | CA2422717A1 (xx) |
| EA (1) | EA006132B1 (xx) |
| HK (1) | HK1084109A1 (xx) |
| IL (1) | IL154685A0 (xx) |
| MX (1) | MXPA03003397A (xx) |
| NO (1) | NO325259B1 (xx) |
| NZ (1) | NZ524675A (xx) |
| PL (1) | PL361887A1 (xx) |
| WO (1) | WO2002032863A1 (xx) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03003397A (es) | 2000-10-20 | 2004-06-30 | Biovitrum Ab | N1-(bencensulfonil)indoles sustituidos en las posiciones 2-, 3-, 4-, o 5 y su uso en terapia. |
| HUP0303756A3 (en) * | 2000-11-02 | 2009-08-28 | Wyeth Corp | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands and process for their preparation and pharmaceutical compositions containing them |
| US7034029B2 (en) | 2000-11-02 | 2006-04-25 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| WO2002041889A2 (en) * | 2000-11-24 | 2002-05-30 | Smithkline Beecham P.L.C. | Indolsulfonyl compounds useful in the treatment of cns disorders |
| IL156518A0 (en) * | 2000-12-22 | 2004-01-04 | Wyeth Corp | Heteocyclylalkylindole or-azaindole compounds as 5-hydroxytryptamine-6 ligands |
| BR0210291A (pt) | 2001-06-11 | 2004-07-13 | Biovitrum Ab | Compostos de sulfonamida substituìdos, processo para sua preparação e seu uso como medicamento para o tratamento de distúrbios do sistema nervoso central, obesidade e diabetes do tipo ii |
| EP1401812B1 (en) * | 2001-06-15 | 2006-06-28 | F. Hoffmann-La Roche Ag | 4-piperazinylindole derivatives with 5-ht6 receptor affinity |
| US20040242589A1 (en) * | 2001-08-07 | 2004-12-02 | Bromidge Steven Mark | 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| CN101050215A (zh) * | 2001-12-28 | 2007-10-10 | 阿卡蒂亚药品公司 | 作为单胺受体调节剂的螺氮杂环化合物 |
| EP1956004B1 (en) * | 2002-03-27 | 2012-06-13 | Glaxo Group Limited | Quinoline derivatives and their use as 5-HT6 ligands |
| WO2003101987A1 (en) * | 2002-05-30 | 2003-12-11 | Neurosearch A/S | 3-substituted quinuclidines and their use |
| CN1293053C (zh) | 2002-06-05 | 2007-01-03 | 弗·哈夫曼-拉罗切有限公司 | 作为5－ht6－受体调节剂用于治疗cns－病症的1－磺酰基－4－氨基烷氧基吲哚衍生物 |
| US7943639B2 (en) | 2002-06-20 | 2011-05-17 | Proximagen Limited | Compounds |
| AU2003243091A1 (en) * | 2002-06-20 | 2004-01-06 | Biovitrum Ab (Publ) | New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| JP4267573B2 (ja) | 2002-09-17 | 2009-05-27 | エフ．ホフマン−ラ ロシュ アーゲー | ２，４−置換インドールおよびそれらの５−ｈｔ６モジュレーターとしての使用 |
| BR0315317A (pt) * | 2002-10-18 | 2005-09-06 | Hoffmann La Roche | 4-piperazinil benzenossulfonil indóis com afinidade para o receptor de 5-ht6 |
| EP1581492B1 (en) * | 2002-11-28 | 2008-07-16 | Suven Life Sciences Limited | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| TW200418830A (en) * | 2003-02-14 | 2004-10-01 | Wyeth Corp | Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| WO2004108671A1 (en) * | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them |
| RS20060035A (xx) | 2003-07-22 | 2008-08-07 | Arena Pharmaceuticals Inc., | Derivati diaril i arilheteroaril uree kao modulatori receptora 5-ht2a serotonina korisni u profilaksi i lečenju poremećaja u vezi sa njima |
| SE0302760D0 (sv) * | 2003-10-20 | 2003-10-20 | Biovitrum Ab | New compounds |
| TW200522944A (en) * | 2003-12-23 | 2005-07-16 | Lilly Co Eli | CB1 modulator compounds |
| JP2010519171A (ja) * | 2006-02-17 | 2010-06-03 | メモリー・ファーマシューティカルズ・コーポレイション | ５−ｈｔ６受容体親和性を有する化合物 |
| ES2398299T3 (es) | 2006-07-03 | 2013-03-15 | Proximagen Ltd. | Indoles como moduladores de 5-HT6 |
| AU2008225753A1 (en) | 2007-03-13 | 2008-09-18 | Proximagen Limited | Tricyclic isoquinoline derivatives for treatment of obesity |
| ES2389958T3 (es) * | 2007-03-21 | 2012-11-05 | Glaxo Group Limited | Uso de derivados de quinolina en el tratamiento del dolor |
| CN101730680A (zh) * | 2007-05-24 | 2010-06-09 | 记忆医药公司 | 具有5-ht6受体亲和力的4’取代的化合物 |
| WO2009023844A2 (en) * | 2007-08-15 | 2009-02-19 | Memory Pharmaceuticals Corporation | 3' substituted compounds having 5-ht6 receptor affinity |
| EP2254564A1 (en) | 2007-12-12 | 2010-12-01 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US20100016297A1 (en) * | 2008-06-24 | 2010-01-21 | Memory Pharmaceuticals Corporation | Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
| US20100022581A1 (en) * | 2008-07-02 | 2010-01-28 | Memory Pharmaceuticals Corporation | Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity |
| US20100029629A1 (en) * | 2008-07-25 | 2010-02-04 | Memory Pharmaceuticals Corporation | Acyclic compounds having 5-ht6 receptor affinity |
| US20100056531A1 (en) * | 2008-08-22 | 2010-03-04 | Memory Pharmaceuticals Corporation | Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| UA100192C2 (xx) * | 2008-11-11 | 2012-11-26 | УАЙТ ЭлЭлСи | 1-(арилсульфоніл)-4-(піперазин-1-іл)-1h-бензімідазоли як ліганди 5-гідрокситриптаміну-6$1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы как лиганды 5-гидрокситриптамина-6 |
| WO2011088836A1 (en) | 2010-01-25 | 2011-07-28 | H. Lundbeck A/S | NOVEL 4-(ARYL-4-SULFONYL)-6,6a,7,8,9,10-HEXAHYDRO-4H-4,8,10a-TRIAZA-ACEPHENANTHRYLENE AND 3-ARYLSULFONYL-6,6a,7,8,9,10-HEXAHYDRO-3H-3,8,10a-TRIAZA-CYCLOPENTA[C]FLUORENE DERIVATIVES AS SEROTONIN 5-HT6 LIGANDS |
| AR080375A1 (es) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida |
| PL395469A1 (pl) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Pochodne indoloamin do leczenia chorób osrodkowego ukladu nerwowego |
| CN104725295B (zh) | 2013-12-20 | 2019-05-24 | 广东东阳光药业有限公司 | 芳杂环类衍生物及其在药物上的应用 |
| SG11201610407QA (en) | 2014-07-08 | 2017-01-27 | Sunshine Lake Pharma Co Ltd | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| RS58575B1 (sr) * | 2014-08-16 | 2019-05-31 | Suven Life Sciences Ltd | Aktivni metabolit 1-[(2-bromofenil) sulfonil]-5-metoksi-3-[(4-metil-1-piperazinil) metil]-1h-indol dimezilat monohidrata i dimezilat dihidrat so aktivnog metabolita |
| EP4119141A1 (en) | 2015-06-12 | 2023-01-18 | Axovant Sciences GmbH | Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder |
| TW201720439A (zh) | 2015-07-15 | 2017-06-16 | Axovant Sciences Gmbh | 用於預防及治療與神經退化性疾病相關的幻覺之作為５－ｈｔ２ａ血清素受體的二芳基及芳基雜芳基脲衍生物 |
| WO2017052394A1 (en) | 2015-09-23 | 2017-03-30 | Uniwersytet Jagielloński | Imidazopyridine compounds and their use as 5-ht6 receptor ligands |
| TWI748194B (zh) | 2018-06-28 | 2021-12-01 | 德商菲尼克斯 Ｆｘｒ有限責任公司 | 含有雙環核心部分之新穎lxr調節劑 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW263508B (xx) * | 1991-02-12 | 1995-11-21 | Pfizer | |
| JPH04273857A (ja) * | 1991-02-26 | 1992-09-30 | Taisho Pharmaceut Co Ltd | Ｎ−置換フェニルスルホニルインドール誘導体 |
| JPH04321671A (ja) * | 1991-04-17 | 1992-11-11 | Mitsubishi Petrochem Co Ltd | カルバモイルトリアゾール誘導体およびそれを有効成分とする除草剤 |
| TW263504B (xx) * | 1991-10-03 | 1995-11-21 | Pfizer | |
| EP0773942A1 (en) | 1994-07-26 | 1997-05-21 | Pfizer Inc. | 4-indole derivatives as serotonin agonists and antagonists |
| IT1282797B1 (it) * | 1995-04-21 | 1998-03-31 | Colla Paolo | Pirril-(indolil)-aril-sulfoni e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids |
| AU5772196A (en) | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
| NZ333182A (en) * | 1996-06-06 | 2000-03-27 | Bifodan As | Enteric coating comprising alginic acid and a water soluble binding agent for an oral preparation |
| US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
| DE69724811T2 (de) * | 1996-07-19 | 2004-04-08 | Tularik, Inc., South San Francisco | Pentafluorobenzensulfonamide und analoge |
| JPH10298011A (ja) * | 1997-04-30 | 1998-11-10 | Nippon Soda Co Ltd | ピリジルインドール化合物および農園芸用殺菌剤 |
| US6296876B1 (en) * | 1997-10-06 | 2001-10-02 | Isa Odidi | Pharmaceutical formulations for acid labile substances |
| DE59807829D1 (de) | 1997-10-14 | 2003-05-15 | Lonza Ag | Zweikernige Iridium(I)-phosphinkomplexe und ihre Verwendung als Katalysator in der asymmetrischen Hydroaminierung von Olefinen |
| US6100291A (en) * | 1998-03-16 | 2000-08-08 | Allelix Biopharmaceuticals Inc. | Pyrrolidine-indole compounds having 5-HT6 affinity |
| US6133287A (en) * | 1998-03-24 | 2000-10-17 | Allelix Biopharmaceuticals Inc. | Piperidine-indole compounds having 5-HT6 affinity |
| US6251893B1 (en) * | 1998-06-15 | 2001-06-26 | Nps Allelix Corp. | Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity |
| WO1999065492A1 (en) * | 1998-06-19 | 1999-12-23 | Eli Lilly And Company | Inhibition of serotonin reuptake |
| DK1149078T3 (da) | 1998-12-11 | 2006-07-10 | Univ Virginia Commonwealth | Selektive 5-HT6-receptorligander |
| HU229479B1 (en) * | 2000-02-16 | 2014-01-28 | Glaxo Group Ltd | Pyrimidine-4-one derivatives |
| AU2002215608B2 (en) * | 2000-06-28 | 2004-12-09 | Smithkline Beecham P.L.C. | Wet milling process |
| US6818639B2 (en) * | 2000-07-21 | 2004-11-16 | Biovitrum Ab | Pharmaceutical combination formulation and method of treatment with the combination |
| MXPA03003397A (es) | 2000-10-20 | 2004-06-30 | Biovitrum Ab | N1-(bencensulfonil)indoles sustituidos en las posiciones 2-, 3-, 4-, o 5 y su uso en terapia. |
| US7034029B2 (en) * | 2000-11-02 | 2006-04-25 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| HUP0303756A3 (en) | 2000-11-02 | 2009-08-28 | Wyeth Corp | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands and process for their preparation and pharmaceutical compositions containing them |
| EP1341783A1 (en) * | 2000-11-21 | 2003-09-10 | Smithkline Beecham Plc | Isoquinoline derivatives useful in the treatment of cns disorders |
| WO2002041889A2 (en) | 2000-11-24 | 2002-05-30 | Smithkline Beecham P.L.C. | Indolsulfonyl compounds useful in the treatment of cns disorders |
| US6630406B2 (en) * | 2001-05-14 | 2003-10-07 | Axcelis Technologies | Plasma ashing process |
| US6951823B2 (en) * | 2001-05-14 | 2005-10-04 | Axcelis Technologies, Inc. | Plasma ashing process |
| EP1401812B1 (en) * | 2001-06-15 | 2006-06-28 | F. Hoffmann-La Roche Ag | 4-piperazinylindole derivatives with 5-ht6 receptor affinity |
| US7279353B2 (en) * | 2003-04-02 | 2007-10-09 | Micron Technology, Inc. | Passivation planarization |
| SE0302760D0 (sv) * | 2003-10-20 | 2003-10-20 | Biovitrum Ab | New compounds |
-
2001
- 2001-10-19 MX MXPA03003397A patent/MXPA03003397A/es active IP Right Grant
- 2001-10-19 EA EA200300492A patent/EA006132B1/ru not_active IP Right Cessation
- 2001-10-19 BR BR0114552-5A patent/BR0114552A/pt not_active IP Right Cessation
- 2001-10-19 AU AU9619301A patent/AU9619301A/xx active Pending
- 2001-10-19 EP EP01977043A patent/EP1326830A1/en not_active Withdrawn
- 2001-10-19 WO PCT/SE2001/002319 patent/WO2002032863A1/en active IP Right Grant
- 2001-10-19 NZ NZ524675A patent/NZ524675A/en unknown
- 2001-10-19 CA CA002422717A patent/CA2422717A1/en not_active Abandoned
- 2001-10-19 AU AU2001296193A patent/AU2001296193B2/en not_active Ceased
- 2001-10-19 IL IL15468501A patent/IL154685A0/xx unknown
- 2001-10-19 KR KR1020037005482A patent/KR100823908B1/ko not_active IP Right Cessation
- 2001-10-19 PL PL36188701A patent/PL361887A1/xx unknown
- 2001-10-22 US US10/037,110 patent/US7087750B2/en not_active Expired - Fee Related
-
2003
- 2003-04-08 NO NO20031589A patent/NO325259B1/no not_active IP Right Cessation
-
2005
- 2005-02-11 US US11/057,033 patent/US7524839B2/en not_active Expired - Fee Related
-
2006
- 2006-04-11 HK HK06104346.7A patent/HK1084109A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200300492A1 (ru) | 2003-10-30 |
| EP1326830A1 (en) | 2003-07-16 |
| NO20031589L (no) | 2003-05-28 |
| US7524839B2 (en) | 2009-04-28 |
| PL361887A1 (en) | 2004-10-04 |
| NO20031589D0 (no) | 2003-04-08 |
| MXPA03003397A (es) | 2004-06-30 |
| HK1084109A1 (en) | 2006-07-21 |
| NZ524675A (en) | 2004-09-24 |
| NO325259B1 (no) | 2008-03-17 |
| WO2002032863A1 (en) | 2002-04-25 |
| AU2001296193B2 (en) | 2006-04-27 |
| US7087750B2 (en) | 2006-08-08 |
| BR0114552A (pt) | 2003-07-01 |
| US20020165251A1 (en) | 2002-11-07 |
| US20050256106A1 (en) | 2005-11-17 |
| CA2422717A1 (en) | 2002-04-25 |
| AU9619301A (en) | 2002-04-29 |
| KR20030038825A (ko) | 2003-05-16 |
| KR100823908B1 (ko) | 2008-04-21 |
| EA006132B1 (ru) | 2005-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1084109A1 (en) | 2-,3-,4-,or 5-substituted-n1-(benzensulfonyl) indoles and their use in therapy 2- | |
| AU2001293553A1 (en) | Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment | |
| GB0109537D0 (en) | Well treatment fluids and methods for the use thereof | |
| HRP20060251B1 (hr) | Supstituirani oksazolidinoni i njihova uporaba | |
| GB0109414D0 (en) | Well treatment fluids and methods for the use thereof | |
| HUP0400069A3 (en) | Pharmaceutical combinations and their use in preventing and treating the thrombosis | |
| AU4196801A (en) | Chordin-like-2 molecules and uses thereof | |
| SI1143997T1 (en) | Tumor necrosis factor antagonists and their use in endometriosis treatment | |
| HUP0203811A3 (en) | Use of polymeric material in the treatment of hard surfaces | |
| AU2868601A (en) | Biaryl compounds, their preparation and their use in therapy | |
| AU2001266229A1 (en) | Hcn polypeptides and polynucleotides and their use in therapy | |
| PL347542A1 (en) | Therapeutic product and its use | |
| EP1230353A4 (en) | BIFUNCTIONAL MOLECULES AND THEIR USE FOR INHIBITING PROTEIN-PROTEIN INTERACTIONS | |
| GB0011052D0 (en) | Medical device and use thereof | |
| PL363048A1 (en) | Azabicyclic derivatives and their therapeutic use | |
| GB0026134D0 (en) | Peptides and their use | |
| GB0028879D0 (en) | Adsorbents and their use | |
| GB2363708B (en) | Combination mat and bag | |
| AU6091299A (en) | Treatment device, treatment bed to be used therein and the use thereof | |
| HUP9900045A3 (en) | Improved leukaemic blood-based product and their use in therapy | |
| GB9929581D0 (en) | Comjpositions and their use | |
| HUP0201800A2 (en) | Novel calpains and their use | |
| EP1229924A4 (en) | TARGETED BIFUNCTIONAL MOLECULES AND THERAPIES THEREFORE | |
| GB0026428D0 (en) | Hydroimidazolone derivatives and their use in therapy | |
| GB0017028D0 (en) | Peptides and their therapeutic use |